Free Webinar on Cancer Immunotherapy! Register now. It will be held March 20th with Dr. Jedd Wolchok Chief, Melanoma & Immunotherapeutics Service Memorial Sloan-Kettering Cancer Center, and Dr. Tibor Keler from Celidex Therapudics

Quoted from: http://www.the-scientist.com/?articles.view/articleNo/39240/title/Tools-and-Strategies-Driving-Cancer-Immunotherapy/

"Tools and Strategies Driving Cancer Immunotherapy
The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy."

FREE Webinar

Thursday March 20, 2014
2:30 - 4:00 p.m. Eastern Time
Register Now

A number of labs in the pharma/biotech industry and in academia are now focusing their efforts on new ways to modulate the immune system to target cancer. Advances, both in understanding immune pathways and in developing tools to target and exploit these pathways, have led to remarkable progress in this relatively new field. The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy. Attendees can interact with the experts during the live webinar by asking questions and sharing their experiences on this topic.

Topics to be covered:

• Basic concepts underlying immunomodulation for oncology
• New drug entities: immunomodulatory agents, vaccines, monoclonal antibodies, and more
• Challenges in drug development
• New tools for screening and validation
• Use of biomarkers for targeted therapies

Register Now

Meet the Speakers:

Dr. Jedd Wolchok
Chief, Melanoma & Immunotherapeutics Service
Memorial Sloan-Kettering Cancer Center

Dr. Tibor Keler
Senior Vice President and Chief Scientific Officer
Celldex Therapeutics